FindTrial
Sign In

Retrospective analysis of the feasibility and safety of day-time thoracoscopic lobectomy based on propensity score matching

Retrospective analysis of the feasibility and safety of day-time thoracoscopic lobectomy based on propensity score matching

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084282
Enrollment
Unknown
Registered
2024-05-14
Start date
2024-05-15
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

day surgery group:none

Sponsors

Nanjing Drum Tower Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Have undergone thoracoscopic lobectomy; (2) Pulmonary nodules were the primary diagnosis; (3) Maximum diameter of lesion = 3 cm; (4) Patient age >18 years old; (5) ASA score is less than 3 points.

Exclusion criteria

Exclusion criteria: (1) Combined with serious underlying diseases; (2) Receiving preoperative neoadjuvant therapy; (3) Incomplete clinical data or follow-up; (4) Multiple metastases or unresectable were found during the operation; (5) Conversion to thoracotomy.

Design outcomes

Primary

MeasureTime frame
Feasibility and safety of day surgery model for thoracoscopic lobectomy;Day surgery completion rate of thoracoscopic lobectomy;—

Secondary

MeasureTime frame
Day surgery readmission rate;—

Countries

China

Contacts

Public ContactZhao Gefei

Nanjing Drum Tower Hospital

zgf6160@sina.com+86 188 1301 9151

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026